To evaluate the biochemical and molecular mechanisms leading to glomerulosclerosis and the variable development of atherosclerosis in patients with familial lecithin cholesterol ester transferase (LCAT) deficiency (FLD), we generated LCAT knockout (KO) mice and crossbred them with apolipoprotein (apo) E KO, low density lipoprotein receptor (LDLr) KO Despite decreased HDL, aortic atherosclerosis was significantly reduced (-35% to -99%) in all mouse models with LCAT deficiency.
INTRODUCTION
As the key enzyme responsible for the esterification of free cholesterol present in circulating lipoproteins, LCAT plays a major role in HDL metabolism (1) . Several lines of evidence that include epidemiological data, transgenic animal studies and more recently prospective human clinical trials (2) (3) (4) (5) (6) indicate that increased plasma HDL levels protect against the development of atherosclerosis. One of several proposed functions of HDL as an anti-atherogenic lipoprotein is to facilitate reverse cholesterol transport, a process by which cholesterol is transported from peripheral cells to the liver for removal from the body (7, 8) . LCAT may play a major role in this process by maintaining a free cholesterol gradient between peripheral cells and the HDL particle surface, thus promoting free cholesterol efflux (1) . The newly generated cholesteryl esters (CE) accumulating in the HDL core may be transferred directly to the liver via whole particle and/or selective uptake (9, 10) . Alternatively HDL-CE may be transferred to apoB-containing lipoproteins as a result of the activity of CETP (8) .
The important role that LCAT plays in HDL metabolism has been established by the identification and characterization of patients with LCAT deficiency. Mutations in the human LCAT gene result either in familial LCAT deficiency (FLD) or in fish eye disease (FED). FED patients have a partial deficiency of LCAT function leading to hypoalphalipoproteinemia and the development of corneal opacities (11, 12) . FLD patients have a total deficiency of LCAT function (12, 13) . In addition to hypoalphalipoproteinemia and corneal opacities, many FLD patients also develop a mild normochromic, normocytic anemia, proteinuria and/or renal dysfunction (14) (15) (16) .
The mild hemolytic anemia in FLD appears to be secondary to changes in red blood cell membrane lipids resulting from altered cholesterol metabolism (17, 18) . Glomerulosclerosis, the major cause of morbidity and mortality in FLD, may ultimately lead to renal failure in the fourth or fifth decade of life (19, 20) , but its pathogenesis is poorly understood. Likewise, the role of LCAT in modulating the development of atherosclerosis in these patients remains unclear.
Despite reduced plasma HDL, many patients with FLD or FED do not appear to have an increased risk for developing cardiovascular disease (21) . Nevertheless, premature coronary heart disease has been documented angiographically and clinically in a subset of these patients (22) (23) (24) (25) (26) (27) . LCAT overexpression has been shown to enhance aortic atherosclerosis in LCAT transgenic mice (28, 29) but decrease atherogenesis in LCAT transgenic rabbits (30) . The mechanisms by which LCAT modulates the development of glomerulosclerosis and atherosclerosis in patients with FLD remain unknown.
We (31) and others (32) have previously described the generation of LCAT-KO mice. On a regular chow diet these animals have markedly reduced total cholesterol, HDL-cholesterol and apoA-I levels (31, 32) . In the present study we characterize the lipid, ophthalmologic, hematological, renal and cardiovascular organ systems of LCAT-KO mice on both regular and high fat/high-cholesterol (HF/HC) diets. LCAT-KO mice develop a clinical phenotype similar to human patients with FLD. In addition to severe hypoalphalipoproteinemia, LCAT-KO mice present with normochromic normocytic anemia and glomerulosclerosis. Our findings indicate that the induction of LpX by the HF/HC diet is associated with the development of glomerulosclerosis in these mice. We also report that, in addition to decreased HDL, LCAT deficiency reduces the plasma levels of apoB-containing lipoproteins by upregulating LDLreceptor gene expression. Despite the low plasma HDL levels, these changes in the plasma lipid profile lead to markedly reduced aortic atherosclerosis in mice with LCAT deficiency. These combined findings provide important new insights into the role that LCAT plays in the development of glomerulosclerosis and atherosclerosis in LCAT deficient states.
METHODS
Animals and diet -Homozygous LCAT knockout mice (31) were backcrossed to strain C57BL/6 for 8 generations. LCAT-KO mice were crossbred with apoE-KO mice (33) , LDL receptor KO mice (34) and CETP-Tg mice (35) with C57BL/6 background. Control C57BL/6 mice were obtained from Charles River (Wilmington, MA). The animals were 25-30g at the beginning of the study. Mice first maintained on a regular NIH-07 chow diet containing 5% fat (Ziegler Brothers Inc., Gardners, PA) were put on a HF/HC diet containing 15% fat (ratio of polyunsaturated to saturated fatty acids = 0.69), 1.25% cholesterol and 0.5% cholic acid (36) .
Measurement of plasma lipids, lipoproteins, apolipoproteins, LCAT activity and cholesterol
esterification rate (CER) -Total cholesterol and triglycerides (Sigma, St. Louis, MO), as well as free cholesterol and phospholipids (Wako, Osaka, Japan) concentrations were measured in 12µl aliquot of plasma using commercial kits and the Hitachi 911 automated chemistry analyzer (Boehringer-Mannheim, Indianapolis, IN). HDL-cholesterol was determined after dextran sulfate-Mg 2+ (Ciba-Corning, Oberlin, OH) or heparin (Sigma) CaCl 2 precipitation of apoB containing lipoproteins (37, 38) . Mouse apoA-I, A-II and apoB were quantitated by a sandwich enzyme linked immunosorbent assay (31, 39) . Plasma lipoproteins were analyzed by gel filtration on two Superose 6 columns in series (FPLC, Pharmacia, Piscataway, NJ) at 0.3ml/min in PBS containing 0.1mM EDTA and 0.02% sodium-azide. The LCAT activity was determined as previously described (40) , using 40µl of mouse plasma. The CER was assessed by determining the rate of esterification of 14 C-cholesterol using 125µl of mouse plasma (41) .
Characterization of lipoprotein fractions -Lipoproteins were obtained from 2 ml of pooled plasma by sequential ultra-centrifugation (42) and their morphology was assessed by negative staining electron microscopy (43) . Plasma lipoprotein electrophoresis as well as immunofixation electrophoresis (IFE) were carried out in agarose gels (REP Vis Cholesterol kit, Helena Labs., Beaumont, TX). Rabbit anti-mouse apoC-I, C-II and C-III goat anti-human (Biodesign International, Kennebunk, ME), and sheep anti-mouse albumin-IgG fraction (The Binding Site Inc., San Diego, CA) were used for IFE. Patterns were developed by staining lipids (Fat Red 7B, Sigma) and/or proteins (Amido Black 10B; Paragon Blue, Beckman Coulter Inc., Brea, CA).
Lp-X in mouse plasma was specifically analyzed by the polyanion precipitation method (44) .
Briefly, after electrophoresis of plasma samples in a 0.5% agar gel (Agar Noble, Difco Labs, Detroit, MI), lipoproteins were precipitated in a solution containing heparin and MgCl 2 . Gels were evaluated by visually observing the development of white precipitates, by staining for lipids with Fat Red 7B, and by immunofixation using the above antibodies. Light and Electron microscopy analysis of renal lesions -The kidneys were perfusion fixed as previously described (45) . Briefly, the aorta was cannulated below the renal arteries, and the kidneys were perfused with buffered 2% paraformaldehyde. For light microscopy coronal sections were embedded in methacrylate and sections were stained with periodic acid Schiff.
Alternatively the sections were embedded in OCT compound, frozen and stained with oil red-O.
A subset of kidneys were fixed in 3% paraformaldehyde / 0.2% glutaraldehyde / 0.2M Na Cacodylate, pH 7.4 and sections were stained in 0.05% filipin (Sigma). Slides were analyzed with a Zeiss microscope, using excitation filter BP 360 for filipin, without the observer being aware of the animal grouping. Lesions were scored on a 1-4+ grading scale (45) . For electron microscopy, cortical regions containing glomeruli were sectioned and photographs were obtained of at least three glomeruli in each mouse.
Histological analysis of aortic lesions -Hearts and upper aortas were dissected and placed in 0.9% saline, followed by fixation in 4% formaldehyde for 24 hours and then 10% formaldehyde for 5 days. The mean aortic lesion areas were quantitated from 5 cross sections per mouse as previously described (46) . were similarly also analzed by western blot using anti mouse apoA-I, apoA-II and apoE IgG (Biodesign, Saco, ME).
Preparation of labeled targets for hybridization -
Statistical analysis -Data are expressed as mean ± SEM. The statistical significance of the differences of the mean between two groups was evaluated using the Student's T-test.
Differences in mean aortic lesion areas were evaluated using the Mann-Whitney test (Instat, GraphPad Software Inc, San Diego, CA).
RESULTS
Plasma LCAT activity, lipids, apolipoproteins and lipoproteins -The changes in the lipid profile and apolipoproteins in the two study groups of mice before and 16 weeks after a HF/HC diet are summarized in Table 1 . Compared to controls, the plasma LCAT activity was reduced by 99% in LCAT-KO mice. On a regular chow diet the plasma levels of total cholesterol, phospholipids, CE, HDL-cholesterol, apoA-I and apoA-II of LCAT-KO mice were decreased to 25, 54, 7, 14, 10 and 23% of controls, respectively, whereas the plasma triglycerides levels increased by 50% (p<0.01,all). The non HDL-cholesterol and apoB levels were similar in both study groups. On the HF/HC diet, the plasma levels of a total cholesterol, phospholipids, CE, HDL-cholesterol, non HDL-cholesterol, apoA-I, apoA-II and apoB of LCAT-KO mice were decreased to 45, 48, 44, 6, 52, 17, 50 and 45% of controls, respectively (p<0.01; all) whereas the plasma triglycerides levels remained unchanged. The plasma CE levels dramatically increased as a result of the HF/HC diet in both controls and LCAT-KO mice. Of particular interest was the increase in the CE/total cholesterol ratio from 21% to 76%, indicating an alternate pathway for the esterification of cholesterol in LCAT-KO mice. Figure 1 illustrates the FPLC elution profile of the plasma lipoproteins in control and LCAT-KO mice maintained 16 weeks on a HF/HC diet. Most of the cholesterol eluted in the very low/intermediate density lipoproteins (VLDL, IDL) and LDL fractions in both study groups. However, the VLDL-cholesterol, IDL-cholesterol as well as HDL-cholesterol were significantly reduced in LCAT-KO mice. Electron microscopy evaluation of negatively stained lipoprotein fractions revealed discoidal particles forming rouleaux structures (i.e. pre-β HDL) only in the HDL fraction of LCAT-KO mice (Fig. 1, inset) , as previously described (32) . On the HF/HC, the morphology of HDL from control mice did not change, whereas there was an increase in the mean diameter of the small spherical particles in the HDL size range of the LCAT-KO mice (10.9±0.4nm on chow vs. 14.5±0.4nm on HF/HC diet).
In addition the proportion of discoidal particles in the HDL fraction from LCAT-KO mice decreased from 14% to 4% after the HF/HC diet (p<0.05). LDL of LCAT-KO mice were polydisperse consisting of smaller 19.6±1.0nm as well as normal 33.1±1.4 nm spherical lipoproteins and some larger structures 66.7±1.8nm in size, whereas those of control mice consisted in particles of 28.0±1.8nm in diameter. The sizes of the particles present in the LDL fraction of both control and LCAT-KO mice did not significantly change after the HF/HC challenge. Lipoprotein electrophoresis (Fig 2A; middle panel) showed a virtual absence of α-lipoproteins in the plasma of LCAT-KO mice and increased staining at the application site (indicated by arrows) after a HF/HC diet in both control and LCAT-KO mice ( Fig. 2A) . On agarose gel, an Lp-X like lipoprotein (Fig 2A; middle panel) migrated in the α-globulin fraction (Fig 2A; left panel) . Like human LpX (47), the mouse Lp-X was shown to contain apoC-I, C-II and C-III ( Fig. 2A ; right panel) and albumin (data not shown) by immunofixation. On agar gel, mouse Lp-X which migrated anodally (Fig. 2B) 2.3±0.5%, p<0.01) as well as reticulocytes (13.5±4.1 vs. 3.2±1.4%, p<0.04) was increased in LCAT-KO mice compared to controls, indicating increased red blood cell hemolysis. As described in FLD patients (17, 18, 48) , the osmotic fragility tests showed that red blood cells from LCAT-KO mice were more resistant to hemolysis than those of controls (5.3±1.5 vs. 43.7±3.1 % hemoglobin leakage in 0.5% NaCl, and 86.3±3.5 vs. 97.7±2.1% in 0.4% NaCl, p<0.01, all).
Renal function -Plasma samples from LCAT-KO and control mice were collected before and after the HF/HC challenge and analyzed for albumin, blood urea nitrogen and creatinine. On either diet no significant difference between the two groups was detected (data not shown).
However, after a HF/HC diet, proteinuria was detected by electrophoresis and IFE in 10 out of 11 LCAT-KO mice urine samples, while the urine samples from all 11-control mice were negative (data not shown).
Kidneys -Histologic lesions were only present in a subset of LCAT-KO mice on the HF/HC diet (i.e. those presenting with Lp-X). The kidneys of the other mice were normal. The lesions consisted of an increase in mesangial matrix ( Figure 3A-B Depositions of electron dense material in the capillary lumen and mesangial regions were evident. The mesangial regions contained an increased amount of extracellular matrix, and there were irregular, but prominent zones containing lucent lacunae. Occasional cells resembling macrophages were present within the mesangium. No changes were seen in either the peripheral basement membrane or the podocytes. In particular, the pedicels were intact. Unlike controls, a subset of LCAT-KO mice on a HF/HC diet accumulated lipids within their glomeruli, which were detected by oil-red-O staining ( Figure 3E-F) . The glomeruli of these LCAT-KO mice had increased free cholesterol content compared to those of controls, as shown on filipin fluorescence stained sections ( Figure 3G-H) . Renal lesions were only present in LCAT-KO mice in which LpX was detected in plasma. No renal lesions were detected in heterozygous LCAT-KO mice.
Effect of LCAT deficiency on the plasma cholesterol levels and atherosclerosis in apoE-KO,
LDLr-KO and CETP-Tg mice-LCAT deficiency reduced the plasma levels of TC, CE and non-HDL-cholesterol (Fig. 4) in apoE-KO, LDLr-KO and CETP-Tg mice (p<0.05; all). -The mean aortic lesion area of apoE-KO and LCAT-KO x apoE-KO mice maintained on a regular chow diet and that of LCAT-KO, LDLr-KO, LCAT-KO x LDLr-KO, CETP-Tg, LCAT-KO x CETP-Tg and control mice maintained 16 weeks on a HF/HC diet was quantitated from 5 cross sections of the proximal aortas (Fig 5) . LCAT deficiency significantly reduced the mean aortic lesion area in C57BL/6 (-85%), apoE-KO (-51%), LDLr-KO (-35%), and CETP-Tg (-99%) mice. Table II summarizes the changes in hepatic gene expression induced by LCAT deficiency in mice. Out of 6500 possible transcripts, the expressions of 51 transcripts were altered by greater than 2-fold in LCAT-KO compared to control mice. Besides LCAT mRNA, the transcripts of Cyp 7α hydroxylase, the rate-limiting enzyme for bile synthesis as well as Squalene Epoxydase, involved in the cholesterol biosynthetic pathway, were down regulated in LCAT-KO mice livers. Of particular interest is the upregulation of the LDL receptor and apoE whose increased expressions were also confirmed by Western blot hybridization analysis (Fig 6) . Despite no differences in their mRNA levels, apoA-I and apoA-II plasma levels were reduced in LCAT-KO mice.
Analysis of differentially expressed hepatic genes in LCAT-KO mice-

DISCUSSION
In the present study we have investigated potential mechanisms leading to renal disease and altered atherogenic risk in LCAT-KO, and LCAT-KO mice crossed with atherosclerosissusceptible mouse models. LCAT-KO mice present with a clinical phenotype similar to patients with FLD, including normochromic normocytic anemia, glomerulosclerosis, hypoalphalipoproteinemia and hypertriglyceridemia. In addition, LCAT deficiency alters the plasma levels of the pro-atherogenic apoB containing lipoproteins by modulating the hepatic expression of the LDLr and apoE, which despite decreased HDL levels, leads to reduced atherogenic risk.
LCAT deficiency in mice markedly reduces total cholesterol, HDL-cholesterol and apoA-I levels as well as increases pre-β HDL and triglyceride levels (31, 32) . Surprisingly, on the HF/HC diet LCAT-KO mice had significantly lower plasma levels of the proatherogenic apoB- Thus, the renal lesions in LCAT-KO mice lead to abnormal renal function.
The pathogenesis of renal injury in FLD is poorly understood. Some investigators have suggested that the renal damages observed in FLD may be immune-complex and complement mediated (20, 65) and may be further exacerbated by the accumulation of oxidized phospholipids in the glomeruli (67) . It has also been suggested that large LDL particles as well as Lp-X trapped in capillary loops induce endothelial damage and vascular injury in the kidneys of FLD patients (51, 54, 63) . However, these abnormal lipoproteins are not always detected in FLD (20) .
It is of interest that LCAT-KO mice developed glomerulosclerosis only while on the HF/HC diet, when the plasma levels of apoB-containing lipoproteins were increased. Both large LDL
and Lp-X were present in the plasma of LCAT-KO mice only on the HF/HC diet. Furthermore, renal lesions were only detected in the group of mice that accumulated Lp-X. These findings provide strong support for the importance of large LDL and Lp-X in the development of renal disease in FLD (68) .
In patients with LCAT deficiency the atherogenic risk is variable. The mechanisms leading to altered atherosclerosis poorly understood. Despite low HDL, many FLD and FED patients do not appear to be at increased risk of developing premature coronary artery disease (21) . However, some patients presenting with severe coronary artery disease have been reported (22) (23) (24) (25) (26) (27) 69) . Decreased plasma LDL levels have been reported in most (12, 13, (49) (50) (51) (52) (53) , but not all (23, 27) patients with LCAT deficiency, reflecting different genetic backgrounds. This same variability in apoB containing lipoproteins levels can be observed in apoE-KO, LDLr-KO and CETP-Tg mice crossed with LCAT-KO mice, where the apoB levels vary according to genetic background. Interestingly, in contrast to LCAT deficient patients with normal or reduced apoB levels, patients with increased triglycerides and apoB levels (23, 27) have been shown to have increased cardiac risk. These patients have delayed catabolism of LDL (70) . These combined data suggest that, in LCAT deficient states, the plasma levels of the proatherogenic apoBcontaining lipoproteins, rather than anti-atherogenic HDL, modulate atherogenic risk.
Additionally, in contrast to patients with Tangier disease, who cannot generate pre-β HDL, (71) LCAT deficiency results in increased plasma levels of this nascent lipoprotein particle, the most effective plasma cholesterol acceptor. Thus, despite reduced HDL, the process of reverse cholesterol transport may still function in LCAT deficiency. 
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